Conference Call to be Held on
March 30, 2023
RANCHO
CORDOVA, Calif., March 28,
2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc.
(Nasdaq: THMO), a market leader in automated cell processing and
point-of-care, autologous cell-based therapies, today announced
that the Company will release its financial results for the year
ended December 31, 2022 and provide a
corporate strategic update on Thursday,
March 30, 2023, after the close of trading. A conference
call and webcast will follow at 1:30 p.m.
PT/ 4:30 p.m. ET.
To participate in the conference call, please dial
1-844-889-4331 (domestic), 1-412-380-7406 (international)
or 1-866-605-3852 (Canada). To
access a live webcast of the call, please
visit: https://thermogenesis.com/investors/news-and-events/events-webcasts/.
A webcast replay will be available on ThermoGenesis' website for
three months by visiting the Investor page of the Company's website
at www.thermogenesis.com.
About ThermoGenesis Holdings, Inc.
ThermoGenesis
Holdings, Inc. develops, commercializes, and markets a range of
automated technologies for CAR-T and other cell-based therapies.
The Company currently markets a full suite of solutions for
automated clinical biobanking, point-of-care applications, and
automation for immuno-oncology, including its semi-automated,
functionally closed CAR-TXpress™ platform, which streamlines the
manufacturing process for the emerging CAR-T immunotherapy market.
For more information about ThermoGenesis, please visit:
www.thermogenesis.com.
Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com
View original
content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-year-ended-december-31-2022-and-provide-a-corporate-strategic-update-301783044.html
SOURCE ThermoGenesis Holdings, Inc.